Innovative Health Practices
ID: 346254Type: Posted
Overview

Buyer

Agency for International Development (USAID)

Award Range

$1B - $1B

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Cooperative Agreement

Opportunity Category

Other

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/346254
Timeline
    Description

    The Agency for International Development (USAID) is seeking participants to collaborate on creating, piloting, and scaling innovative research and development interventions utilizing innovative health practices. The goal is to help reduce disease and mortality rates worldwide, particularly in low-and-middle-income countries (LMICs). USAID is inviting organizations and companies to submit an Expression of Interest (EOI) to generate novel tools and approaches that accelerate and sustain improved health outcomes in LMICs. The agency aims to foster co-creation, co-design, and co-investment to create high-quality partnerships with efficiency in time and resources. This opportunity welcomes collaboration from local partners in LMICs, including the private sector and faith-based organizations, to address health challenges. The funding instrument type is a Cooperative Agreement, and there is no cost sharing or matching requirement. The grant has a total award ceiling and floor of $1,000,000,000, and it is expected to result in three awards. The close date for submissions is February 20, 2028. For more information, contact Sharon D Davis at shdavis@usaid.gov or 202-567-4755.

    Point(s) of Contact
    shdavis@usaid.gov
    Files
    Title
    Posted
    BAA-GH-OAA-2023 Innovative Health Practices.pdf
    Similar Opportunities
    The USAID Global Health Development Innovation Accelerator Broad Agency Announcement
    Active
    Agency for International Development
    The Agency for International Development (USAID) is inviting organizations to participate in the Global Health Development Innovation Accelerator Broad Agency Announcement (BAA), aimed at co-creating and scaling innovative solutions to address critical global health challenges. This initiative encourages a diverse range of eligible applicants, including public and private organizations, non-profits, and institutions of higher education, to submit proposals that demonstrate strong potential impacts on reducing maternal and neonatal mortality, particularly in low- and middle-income countries. The program emphasizes flexibility in partnerships and allows for multiple submissions from applicants, with funding amounts ranging from $250,000 to $2 million, and the application process is strictly time-bound with no extensions available. Interested parties should refer to individual addenda for specific contact information and submission deadlines, as the response dates are established by those addenda.
    Accelerating HIV Vaccine Research and Development in Low- and Middle-Income Countries (LMIC)
    Active
    Agency for International Development
    The United States Agency for International Development (USAID) is seeking expert input through a Request for Information (RFI) aimed at accelerating HIV vaccine research and development in low- and middle-income countries (LMICs). This initiative is designed to gather recommendations on opportunities, challenges, and gaps in HIV vaccine R&D, particularly focusing on collaborative ecosystems, efficient manufacturing, and community engagement. The RFI underscores USAID's commitment to enhancing partnerships and locally-led development in regions significantly impacted by HIV, including outreach to historically black colleges and universities (HBCUs) and minority-serving institutions (MSIs). Interested parties must submit their responses electronically by May 24, 2024, at 5:00 PM EDT, adhering to specific formatting guidelines, and can direct inquiries to Simone Cho at scho@usaid.gov.
    The USAID Global Health Broad Agency Announcement for Research and Development (2018)
    Active
    Agency for International Development
    The United States Agency for International Development (USAID) has issued the Global Health Broad Agency Announcement (BAA) for Research and Development, aimed at fostering innovative solutions to critical global health challenges in developing countries. This BAA invites organizations to collaborate with USAID in co-creating research concepts that address significant health issues, such as maternal and child mortality and the prevention of infectious diseases, without directly soliciting funding proposals. The initiative emphasizes partnerships and cooperative engagements, focusing on the capability of participants to contribute to USAID's health objectives, with evaluations based on potential impact at scale. Interested parties can inquire further by contacting USAID at GH-BAA-2018@usaid.gov, with the BAA remaining open until May 30, 2022, for future Addenda that will provide specific funding information.
    Microbicides Research, Development, and Introduction
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is offering a federal grant opportunity titled "Microbicides Research, Development, and Introduction" aimed at advancing research and innovative activities related to microbicides for HIV prevention. This initiative seeks to support clinical trials and other activities that contribute to the Global Health Initiative's principles, particularly focusing on a woman- and girl-centered approach and strengthening health systems. The funding amounts range from $100,000 to $2,250,000, with no cost-sharing or matching requirements, and interested applicants can contact Kathleen Bumpass at kbumpass@usaid.gov for further information. The closing date for applications is to be determined.
    Frontier Health Markets APS
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is inviting submissions for the Frontier Health Markets (FHM) Annual Program Statement (APS), aimed at enhancing global health outcomes related to maternal and child health, HIV/AIDS, and infectious diseases. This cooperative agreement seeks to engage both U.S. and non-U.S. organizations, including public, private, for-profit, and nonprofit entities, as well as institutions of higher education and international organizations, to submit concept papers for potential funding under various rounds of the APS. The initiative is critical for improving local health markets and fostering private sector involvement in health initiatives. Interested applicants can reach out to Jacquelin Bell at jacbell@usaid.gov for further information, with the closing date for submissions set for February 24, 2028.
    New Partnerships Initiative (NPI) – Global Health
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is offering a funding opportunity through the New Partnerships Initiative (NPI) Global Health Annual Program Statement (APS) aimed at engaging new and underutilized partners to enhance health sector outcomes. This initiative focuses on supporting community-based interventions, particularly in response to COVID-19, by inviting organizations to submit Concept Papers that align with national health policies and emphasize local partnerships. The funding opportunity is significant, with a total ceiling of up to $100 million available for multiple awards, and the closing date for submissions is September 30, 2030. Interested applicants can reach out to USAID at ghnpiaps@usaid.gov for further information and guidance on the application process.
    Augmenting Capacity for Humanitarian Emergencies of Infectious Diseases
    Active
    Agency for International Development
    The Agency for International Development (USAID) is offering a federal grant titled "Augmenting Capacity for Humanitarian Emergencies of Infectious Diseases" aimed at enhancing the preparedness and response capabilities of non-governmental organizations (NGOs) in the face of infectious disease outbreaks. The program seeks to establish standby capacity by improving technical coordination and multi-sectoral responses, particularly in health, nutrition, water, sanitation, and agriculture, to effectively manage humanitarian emergencies. With a total funding ceiling of $8 million for a single award, applicants are required to submit concept notes by April 27, 2018, and can direct inquiries to 720FDA18APS00001@ofda.gov for further clarification on the application process.
    MOMENTUM (Moving Integrated, Quality Maternal, Newborn, and Child Health Services, Voluntary Family Planning, and Reproductive Health Care [MNCH/FP/RH] to Scale)
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is inviting concept papers for the MOMENTUM initiative, aimed at enhancing maternal, newborn, and child health services in high-burden areas, particularly in India. This opportunity seeks innovative proposals that focus on improving health outcomes through evidence-based interventions, capacity building of local health workers, and fostering partnerships with local institutions, with an emphasis on sustainability and alignment with government health strategies. The program anticipates awarding 1-3 grants, with a ceiling of $13 million, and requires concept papers to be submitted by August 21, 2020, with further co-creation workshops planned for selected applicants. For additional information, interested parties can contact Samantha Pierre at spierre@usaid.gov.
    The USAID Fighting Ebola BAA
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is seeking innovative solutions through its Broad Agency Announcement (BAA) titled "The USAID Fighting Ebola BAA," aimed at combating the Ebola epidemic. This initiative invites public, private, for-profit, and non-profit organizations, as well as institutions of higher education and international organizations, to co-create and collaborate on practical innovations that enhance healthcare delivery and control the spread of Ebola. The program emphasizes the importance of developing cost-effective technologies to support healthcare workers on the front lines. Interested applicants must submit their expressions of interest by December 1, 2014, at 11:59 PM for consideration in the second round review, and can reach out to USAID at SubmitEbolaEOI@usaid.gov for further inquiries.
    Promoting Results and Outcomes through Policy and Economic Levers (PROPEL)
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is inviting proposals for the Promoting Results and Outcomes through Policy and Economic Levers (PROPEL) Annual Program Statement (APS), aimed at enhancing equitable and sustainable health services globally. The initiative focuses on improving policy development, sustainable financing, government accountability, and civil society engagement, particularly in the integration of family planning/reproductive health (FP/RH) with maternal and child health (MCH) and HIV/AIDS initiatives. This program is crucial for addressing healthcare system challenges and fostering inclusive health systems through collaboration with local partners, especially youth and vulnerable groups. Interested applicants, including U.S. and non-U.S. public, private, for-profit, and nonprofit organizations, can submit concept papers until the closing date of November 30, 2027, with an estimated total program funding of $180 million available for awards ranging from $0 to $180 million. For further inquiries, applicants may contact LaVietra Shannon at lshannon@usaid.gov or by phone at 202-916-2731.